Upstream Bio Reports Positive Top-Line Results from the Phase 2 VIBRANT Trial of Verekitug for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
2 September 2025
Download
IO Biotech Announces Clinical Improvement in Progression Free Survival Demonstrated in Pivotal Phase 3 Trial of Cylembio® plus KEYTRUDA® (Pembrolizumab) for the Treatment of First-line Advanced Melanoma, but Statistical Significance Narrowly Missed
11 August 2025
Download
Freenome Announces Exclusive License Agreement with Exact Sciences to Commercialize Freenome’s Blood-Based Screening Test for Colorectal Cancer
6 August 2025
Download
SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics
5 August 2025
Download
Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
22 July 2025
Download
Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management
18 July 2025
Download
Neuron23 Announces $96.5 Million Series D Financing and First Patient Dosed in Global Phase 2 NEULARK Clinical Trial of NEU-411 for Early Parkinson’s Disease
25 June 2025
Download
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC
22 May 2025
Download
AbbVie and ADARx Pharmaceuticals Announce Collaboration and License Option Agreement to Develop Next-Generation siRNA Therapies Across Multiple Therapeutic Areas
14 May 2025
Download
Swixx and Biopas Expand Portfolio in Latin America, Securing 9 New Partnership Contracts in One Year
28 April 2025
Download
Aculys Pharma Signs 4.4 Billion Yen Series C Funding Round Agreement
24 March 2025
Download
VISEN Pharmaceuticals Announces the Offer Price and Allotment Results of the Global Offering
21 March 2025
Download
Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline
20 March 2025
Download
Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
17 March 2025
Download
Mineralys Therapeutics Announces Positive Topline Results from Launch-HTN and Advance-HTN Pivotal Trials of Lorundrostat for the Treatment of Uncontrolled or Resistant Hypertension
10 March 2025
Download
Günstiger Zeitpunkt (aus dem FONDS'25 der «Finanz und Wirtschaft» vom Januar 2025)
25 January 2025
Download
Biotech mit hohem Discount
25 January 2025
Download
NiKang Therapeutics® Announces First Patient Dosed in a Phase 1b/2 Study of NKT2152 in Combination with Standard-of-Care in First-Line Regimen for Hepatocellular Carcinoma
21 January 2025
Download
Bluejay Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Brelovitug (BJT-778) for the Treatment of Chronic Hepatitis Delta
21 January 2025
Download
Numab Therapeutics Announces Series C Extension to CHF 180 Million, Completing Oversubscribed CHF 50 Million Financing
9 January 2025
Download
Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseases
8 January 2025
Download
Sai Life Sciences now listed on Indian Stock Exchanges
18 December 2024
Download
Fangzhou Inc. and Bristol Myers Squibb China Join Forces on a Strategic Alliance to Advance Internet Healthcare
18 December 2024
Download
C Ray Therapeutics Completes Over $100 Million Series A+ Financing, Jointly Led by SCGC and TaiLong Capital
16 November 2024
Download
Neurelis Enters $208 Million Agreement to Monetize Intravail Royalties
14 November 2024
Download